AntigenTests.com provides HealthGPO Members and Point-of-Care (POC) providers with competitive pricing and a reliable supply chain for FDA EUA approved Rapid POC COVID-19 tests
LAS VEGAS, NV, Dec. 20, 2021 — McapMediaWire — GPO Plus, Inc. (OTCQB: GPOX), a publicly traded company of diversiﬁed industry-speciﬁc Group Purchasing Organizations or “GPOs”, today announced the oﬃcial launch of AntigenTests.com, a project of HealthGPO. HealthGPO is a Group Purchasing Organization for the Healthcare industry with operations and facilities located throughout the United States.
AntigenTests.com is a project created and managed by HealthGPO. HealthGPO started distributing FDA Emergency Use Authorization (EUA) Rapid Point-of-Care (POC) COVID-19 Antigen Tests and Rapid POC COVID-19 Antibody Tests in October 2020; immediately after the initial FDA EUA’s were granted.
AntigenTests.com solves two major problems typically associated with purchasing POC COVID-19 tests:
- Unreliable supply chains with global shortages, and
- Wildly inconsistent pricing with regular price increases.
HealthGPO addresses these problems with its dedicated team of procurement professionals to ensure its Members have extremely competitive pricing and a consistent and reliable supply chain for POC COVID-19 Antigen Tests and Antibody Tests.
- HealthGPO aggregates the purchasing power of its Members to negotiate discounts with suppliers that are then shared with its Members; saving its Members money!
- HealthGPO’s procurement team works with multiple distributors and vendors to secure the most popular POC COVID-19 tests; creating reliable supply chains!
Point-of-Care providers are encouraged to visit AntigenTests.com to review our pricing and sign up as a Member of HealthGPO. Since we are not charging membership fees at this time, to become a Member all you have to do is complete a purchase.
HealthGPO Members are always incentivized to spread the word because, in the spirit of Group Purchasing, our buying power increases with each new Member. The more buying power we have the better prices we can negotiate and the more money we save our Members!
GPOX President Ron McCormick said, “Over the last year we (HealthGPO) have worked tirelessly to maintain a consistent supply of POC COVID tests while preserving the best and most competitive pricing available.” McCormick Continued, “One of the best things we’ve been able to do is to help POC facilities from getting massive ﬁnes. Due to the COVID test supply shortages, one of our main value propositions has been getting tests delivered the next day! As long as the order is paid for by 6:00 PM Eastern, we can usually get the tests delivered the next business day. Now our Members don’t have to worry about the supply chain issues.”
“Shareholders who looked closely at our ﬁlings could identify that a large portion of our revenue last year (2021) was derived from POC COVID test sales,” said GPOX CEO Brett H. Pojunis. Pojunis continued, “The importance of this project (AntigenTests.com) cannot be overstated! With the emergence of new more contagious COVID variants such as Delta and Omicron, we believe the demand for COVID tests will continue to increase greatly leading to long term growth in this sector. This creates an opportunity for us to grow HealthGPO’s Membership because we are in a position to truly help POC healthcare and medical providers who are struggling to get the tests they need.”
Rapid Point-of-Care COVID-19 Antigen Tests detect the presence or absence of SARS-CoV-2 viral protein which is the virus that causes COVID-19. Rapid Point-of-Care (POC) tests provide results within minutes (depending on the test) and are used to diagnose current or detect past SARS-CoV-2 infections in various settings, such as Physician oﬃces, Urgent care facilities, Pharmacies, School health clinics, long term care facilities, and nursing homes, and temporary locations, such as drive-through sites managed by local organizations.
All COVID-19 tests distributed through AntigenTests.com are authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certiﬁcate of Waiver, Certiﬁcate of Compliance, or Certiﬁcate of Accreditation. AntigenTests.com is dedicated to Point-of-Care medical professionals.
Equity Crowdfunding Page
GPOX is raising $5,000,000 Please visit our crowdfunding page, https://invest.gpoplus.com
Sign up for your FREE account on the GPOX Investor Relations Portal:
Once you Activate your GPOX Investor Account you will have immediate access to real time information available on GPOX. Sign up for alerts (email and SMS) to be the ﬁrst to know about news, SEC Filings, Investor Events, updated Investor Presentations, and more: www.GPOPlus.com/ir.
AntigenTests.com is a project created and managed by HealthGPO that has a dedicated team of procurement professionals to ensure our Members have a consistent supply chain for POC COVID-19 tests with competitive pricing.
Please visit: AntigenTests.com to learn more or call us at 844.998.2433.
HealthGPO is a Group Purchasing Organization or “GPO” for the Healthcare industry. HealthGPO saves its Members money by aggregating purchases, negotiating with vendors, and sharing the discounts. HealthGPO saves its Members time and alleviates headaches by streamlining orders and oﬀering integrated solutions leading to considerable supply chain eﬃciencies.
About GPOPlus+ (GPOX)
Headquartered in Las Vegas, Nevada, GPOPlus+ (OTCQB: GPOX) is a publicly traded company of diversiﬁed industry-speciﬁc Group Purchasing Organizations or “(GPOs”. Our Purpose is to create industry speciﬁc GPOs and our Mission is to create value for our Members, partners, and suppliers while creating long term shareholder value.
We Aggregate, Negotiate + Share!
- Aggregate – We aggregate the purchasing power of our Members.
- Negotiate – We leverage buying power to negotiate discounts.
- Share – We share the discounts with our Members and save them money.
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include statements regarding expected ﬁnancial performance and growth information relating to future events.
Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond the control of the Company and its oﬃcers and managers, and which may cause actual results, performance or achievements to be materially diﬀerent from future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to diﬀer materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these diﬀerences include, but are not limited to; inability to gain or maintain licenses, reliance on unaudited statements, the Company’s need for additional funding, governmental regulation of the cannabis industry, the impact of competitive products and pricing, the demand for the Company’s products, and other risks that are detailed from time-to-time in the Company’s ﬁlings with the United States Securities and Exchange Commission. All statements other than statements of historical fact are statements that could be forward-looking statements. You can typically identify these forward-looking statements through use of words such as “may,” “will,” “can” “anticipate,” “assume,” “should,” “indicate,” “would,” “believe,” “contemplate,” “expect,” “seek,” “estimate,” “continue,” “plan,” “point to,” “project,” “predict,” “could,” intend,” “target,” “potential,” and other similar words and expressions of the future. The Company expresses its expectations, beliefs and projections in good faith and believes that its expectations reﬂected in these forward-looking statements are based on reasonable assumptions. However, there is no assurance that these expectations, beliefs and projections will prove to have been correct. Such statements reﬂect the current views of the Company with respect to its operations and future events, and are subject to certain risks, uncertainties and assumptions relating to its proposed operations, including the risk factors set forth herein. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, the Company’s actual results may vary signiﬁcantly from those intended, anticipated, believed, estimated, expected or planned. In light of these risks, uncertainties and assumptions, any favorable forward-looking events discussed herein might not be realized and occur. The Company has no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed description of the risk factors and uncertainties aﬀecting GPO Plus, Inc. GPOX, please refer to the Company’s recent Securities and Exchange Commission ﬁlings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
GPO Plus’s Contacts:
Shareholder Success Team + Investor Inquiries:
Brett H. Pojunis, CEO Email: firstname.lastname@example.org
Shareholder’s Line: 855.935.GPOX (4769)